TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 67 filers reported holding TRICIDA INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,559,000 | +113.3% | 148,700 | +96.7% | 0.01% | +85.7% |
| Q2 2022 | $731,000 | +85.5% | 75,600 | +57.5% | 0.01% | +75.0% |
| Q1 2022 | $394,000 | +82.4% | 48,000 | +112.4% | 0.00% | +100.0% |
| Q4 2021 | $216,000 | +105.7% | 22,600 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $105,000 | +4.0% | 22,600 | -2.6% | 0.00% | 0.0% |
| Q2 2021 | $101,000 | 0.0% | 23,200 | +21.5% | 0.00% | 0.0% |
| Q1 2021 | $101,000 | -9.0% | 19,100 | +20.9% | 0.00% | 0.0% |
| Q4 2020 | $111,000 | -88.5% | 15,800 | -54.9% | 0.00% | -92.3% |
| Q2 2020 | $962,000 | +164.3% | 35,004 | +126.9% | 0.01% | -7.1% |
| Q4 2018 | $364,000 | +4.6% | 15,424 | +35.3% | 0.01% | -6.7% |
| Q3 2018 | $348,000 | – | 11,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |